N30 raises $30 million for cystic fibrosis drug development

BOULDER – N30 Pharmaceuticals Inc. announced Wednesday that the company closed recently on a $30 million funding round that it expects will be its last before an initial public offering. The money will be used to further the development of therapies that Boulder-based N30 is working on for the treatment

Today's News

Print Edition

Publication Title

More injections sought despite quakes

Investigation into wastewater well remains open GREELEY — NGL Water Solutions DJ LLC, whose fracking-fluid disposal well was linked to earthquakes near the Greeley Airport late last spring, has asked to boost by 20 percent the amount of water it can inject underground, despite ongoing low-level quake activity captured by a

Lists

Columns

Poll

Event Calendar Submit an event

November

SunMonTueWedThuFriSat
      
Colorado Technology Association APEX Awards
WHY SHOULD ANYONE FOLLOW YOU? THINKING LIKE A LEADER
CO-LABS 6th Annual 2014 Governor’s Award for High-Impact Research
Boulder Valley Real Estate Conference & Forecast
      
Advertising

Social Network

 
Facebook Icon
Twitter Icon
LinkedIn Icon